BALTIMORE (WJZ) — Johns Hopkins researchers have received over $30 million in funding from the U.S. Department of Defense for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment.
The treatment is a transfusion of a blood product from COVID-19 survivors that contains antibodies that may help the patient’s immune system fight the virus, researchers say.
{iframe}https://baltimore.cbslocal.com/2020/07/30/johns-hopkins-funding-for-coronavirus-blood-plasma-trials/{/iframe}s